Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users

Difelikefalin, a selective kappa‐opioid receptor agonist with limited central nervous system penetration, is being developed for the treatment of chronic pruritic conditions. This randomized, double‐blind, active‐ and placebo‐controlled, four‐way crossover study was designed to evaluate the abuse po...

Descripción completa

Detalles Bibliográficos
Autores principales: Shram, Megan J., Spencer, Robert H., Qian, Jenny, Munera, Catherine L., Lewis, Michael E., Henningfield, Jack E., Webster, Lynn, Menzaghi, Frédérique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841457/
https://www.ncbi.nlm.nih.gov/pubmed/34708917
http://dx.doi.org/10.1111/cts.13173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841457/
https://www.ncbi.nlm.nih.gov/pubmed/34708917
http://dx.doi.org/10.1111/cts.13173

Ejemplares similares